Tag: global optical genome mapping market

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Is The Projected Market Size Of The Optical Genome Mapping Market By 2029?

The optical genome mapping market size has experienced significant expansion in recent years. This market is forecast to increase from $0.17 billion in 2024 to $0.23 billion in 2025, achieving a compound annual growth rate (CAGR) of 29.3%. The historical development of the market can be attributed to several factors, including a surging demand for advanced genomic analysis tools and techniques, increased research initiatives focused on large-scale genome identification, a rising number of collaborations between instrument manufacturers and hospitals, the adoption of optical genome mapping within research institutions and pharmaceutical companies, and its cost-effectiveness and efficiency enabling rapid and highly accurate analysis of large genomes.

The optical genome mapping market is projected to experience substantial expansion in the coming years. This market is anticipated to reach a valuation of $0.6 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 27.6%. This projected growth during the forecast period is primarily driven by progress in genomic research, a rising need for precision medicine, increased governmental financial support and programs, a strong healthcare infrastructure, and the growing incidence of genetic illnesses and cancer. Key trends identified for the forecast period encompass sophisticated OGM services, various genomic research endeavors, innovations in DNA mapping technologies, general technological progress, and improvements in data analysis tools like AI and ML specifically for processing genomic data.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15882&type=smp

Which Drivers Are Supporting Growth Of The Optical Genome Mapping Market?

The growing requirement for precision medicine is anticipated to fuel the expansion of the optical genome mapping market moving ahead. Precision medicine, a healthcare methodology, tailors medical treatments and preventative measures to specific individual attributes like genetic composition, way of life, and surroundings. The impetus for precision medicine stems from the escalating incidence of chronic illnesses, breakthroughs in genomic technologies, increased financial backing and investment, and patients’ desire for customized care. optical genome mapping bolsters the potential of precision medicine by offering an in-depth and precise comprehension of genomic changes linked to various ailments. For example, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that the FDA cleared 16 new personalized therapies for individuals with rare diseases in 2023, an increase from six in 2022. Consequently, the rising need for precision medicine is stimulating the growth of the optical genome mapping market.

What Are The Segment Types Shaping The Optical Genome Mapping Market?

The optical genome mappingmarket covered in this report is segmented –

1) By Product: Instruments; Consumables And Reagents; Software; Services

2) By Application: Structural Variant Detection; Genome Assembly; Microbial Strain Typing; Other Applications

3) By End-User: Biotechnology And Pharmaceutical Companies; Clinical Laboratories; Academic Research Institutes; Other End-Users

Subsegments:

1) By Instruments: Optical Genome Mapping Systems; Imaging Systems; Detection And Analysis Devices

2) By Consumables And Reagents: DNA Preparation Kits; Labeling Reagents; Flow Cells

3) By Software: Data Analysis Software; Image Processing Software; Mapping Software

4) By Services: Data Analysis Services; Technical Support Services; Training And Consultation Services

What Are The Major Trends Driving The Growth Of The Optical Genome Mapping Market?

Major companies operating in the optical genome mapping market are developing optical genome mapping-based laboratory-developed tests (LDTs) to enhance diagnostic capabilities and provide more precise genomic insights. These optical genome mapping-based LDTs are diagnostic assays designed and implemented within individual clinical laboratories using optical genome mapping (OGM) technology. For instance, in September 2022, Bionano Genomics Inc., a US-based company providing genome analysis software, launched an optical genome mapping-based LDT for facioscapulohumeral muscular dystrophy (FSHD). This OGM-based LDT will enable Bionano Laboratories to offer services to customers seeking to integrate OGM into their diagnostic routines and for research applications with hospitals, pharmaceutical companies, and other parties.

Who Are The Top Performing Companies In The Optical Genome Mapping Market In Recent Years?

Major companies operating in the optical genome mapping market are Agilent Technologies Inc., Illumina Inc., PerkinElmer Genomics, Bio-Rad Laboratories Inc., Qiagen N.V., Cerba Healthcare, GenScript Biotech Corporation, 10x Genomics Inc., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., NanoString Technologies Inc., MedGenome, Element Biosciences, Bionano Genomics Inc., Stratos Genomics, BioSkryb Genomics, Source Genomics, Genoox, Nucleome Informatics Private Limited, Praxis Genomics LLC, Phase Genomics Inc., Daicel Arbor Biosciences, Nabsys, OpGen, Genohub Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/optical-genome-mapping-global-market-report

Which Region Is Expected To Witness The Fastest Growth In The Optical Genome Mapping Market?

North America was the largest region in the optical genome mapping market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the optical genome mapping market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Optical Genome Mapping Market Report:

https://www.thebusinessresearchcompany.com/customise?id=15882&type=smp

Browse Through More Reports Similar to the Global Optical Genome Mapping Market 2025, By The Business Research Company

Optical Measurement Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/optical-measurement-global-market-report

Optical Wavelength Services Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/optical-wavelength-services-global-market-report

Optical Brightener Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/optical-brightener-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Fast Is The Optical Genome Mapping Market Expected to Grow Between 2025 And 2029?

In recent times, the size of the optical genome mapping market has witnessed significant expansion. The market, which was valued at $0.17 billion in 2024, is projected to increase to $0.23 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 29.3%. This sizable growth in the historic period is a result of a heightened demand for superior genomic analysis tools and techniques, extensive research on large-scale genome identification, a greater number of partnerships between equipment producers and hospitals, as well as the implementation of optical genome mapping in research institutions and pharmaceutical companies. Furthermore, the cost-effectiveness and efficiency of these techniques have facilitated quick analysis of large genomes with precise accuracy.

Expectations are high for the optical genome mapping market with predictions suggesting an exponential boost in the size over the ensuing years. The market is forecasted to reach $0.6 billion by 2029, growing at a compound annual rate of 27.6%. Several factors are considered to spur this significant growth during the forecast period. These factors can be listed as follows: progress in genomic investigations, the growing need for precision medicine, enhancement in government funding and related strategies, sturdy healthcare structure, and a rise in commonality of genetic ailments and cancer. The prevailing trends during this forecast period are expected to be the refinement in OGM services, initiatives in genomic research, progression in DNA mapping methodologies, technological evolutions, and improvements in data examination technologies like AI and ML for processing genomic data.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15882&type=smp

What External and Internal Drivers Are Contributing to the Growth of theOptical Genome Mapping Market?

The optical genome mapping market is expected to expand due to a rise in the demand for precision medicine. Precision medicine tailors both medical treatments and prevention strategies to an individual’s own genetic makeup, lifestyle, and environmental conditions. The popularity of this approach is fuelled by an increase in chronic diseases, advancements in genomic technology, growing investment and funding, and the desire for bespoke care from patients. By offering a thorough and precise understanding of genomic variations linked to various diseases, optical genome mapping bolsters the capabilities of precision medicine. For example, the Personalized Medicine Coalition, a non-profit organization based in the U.S, stated that in February 2024, the FDA endorsed 16 new personalized treatments for patients with rare diseases in 2023, more than double the six approved in 2022. Consequently, the rise in demand for precision medicine is fuelling the progression of the optical genome mapping market.

What Segment Types Define the Optical Genome Mapping Market Structure?

The optical genome mappingmarket covered in this report is segmented –

1) By Product: Instruments; Consumables And Reagents; Software; Services

2) By Application: Structural Variant Detection; Genome Assembly; Microbial Strain Typing; Other Applications

3) By End-User: Biotechnology And Pharmaceutical Companies; Clinical Laboratories; Academic Research Institutes; Other End-Users

Subsegments:

1) By Instruments: Optical Genome Mapping Systems; Imaging Systems; Detection And Analysis Devices

2) By Consumables And Reagents: DNA Preparation Kits; Labeling Reagents; Flow Cells

3) By Software: Data Analysis Software; Image Processing Software; Mapping Software

4) By Services: Data Analysis Services; Technical Support Services; Training And Consultation Services

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=15882&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Optical Genome Mapping Market?

North America was the largest region in the optical genome mapping market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the optical genome mapping market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Long-Term Trends Are Transforming the Competitive Landscape of the Optical Genome Mapping Market?

Leading firms in the optical genome mapping market are creating optical genome mapping-focused laboratory-developed tests (LDT) with the goal of increasing diagnostic precision and providing deeper genomic understanding. Optical genome mapping-based laboratory-developed tests (LDTs) are diagnostic tools crafted and utilized within individual clinical labs that use optical genome mapping (OGM) technology. For example, in September 2022, Bionano Genomics Inc., a company from the United States that offers genome analysis software, introduced an optical genome mapping-based LDT for facioscapulohumeral muscular dystrophy (FSHD). This OGM-based LDT application will allow Bionano Laboratories to cater to customers who are looking to incorporate OGM into their diagnostic processes and research collaborations with hospitals, pharmaceutical firms, and other entities.

View the full report here:

https://www.thebusinessresearchcompany.com/report/optical-genome-mapping-global-market-report

What Is the Definition of the Optical Genome Mapping Market?

Optical genome mapping (OGM) is a cutting-edge genomic analysis technique that involves creating high-resolution, large-scale maps of Deoxyribonucleic Acid (DNA) molecules to identify structural variations and genome architecture. This technology leverages optical methods to visualize and analyze long strands of DNA, allowing for the detection of large-scale structural variations such as insertions, deletions, duplications, inversions, and translocations, which are often difficult to identify with traditional sequencing methods.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15882

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#How Has the Optical Genome Mapping Market Growth Performance Trended Historically, And What Lies Ahead?

The marketplace for optical genome mapping has seen substantial expansion in recent years. It’s forecasted to rise from $0.17 billion in 2024 to $0.23 billion in 2025, which equates to a compound annual growth rate (CAGR) of 29.7%. Factors attributing to this growth within the historical period include the heightened demand for sophisticated genomic analysis tools and methods, amplified research into extensive genome identification, and an increase in partnerships between instrument manufacturers and hospitals. Beyond that, the adoption of optical genome mapping by research institutions and pharmaceutical companies, coupled with its cost-effectiveness and efficiency, has facilitated the quick and accurate analysis of large genomes.

What Is the Forecast for the Optical Genome Mapping Market Size Through 2029?

Over the coming years, it is anticipated that the optical genome mapping market will experience vast expansion, with predictions suggesting it will reach $0.63 billion by 2029, reflecting a Compound Annual Growth Rate (CAGR) of 29.4%. This forthcoming development within the optical genome mapping market can be linked to progressive movements in genomic exploration, coupled with the growing necessity for precision medicine and an increase in genetic diseases and cancer prevalence. This expansion is further supported by government funding and initiatives, alongside a strong healthcare framework. Key future trends include the elevation of OGM amenities, initiatives in genomic research, innovation in DNA mapping technologies, technological evolution, and the introduction of advanced data analysis technologies like Artificial Intelligence and Machine Learning for processing genomic data.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15882&type=smp

What are the Key Market Players in Optical Genome Mapping Market and How They’re Evolving?

Major companies operating in the optical genome mapping market are Agilent Technologies Inc., Illumina Inc., PerkinElmer Genomics, Bio-Rad Laboratories Inc., Qiagen N.V., Cerba Healthcare, GenScript Biotech Corporation, 10x Genomics Inc., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., NanoString Technologies Inc., MedGenome, Element Biosciences, Bionano Genomics Inc., Stratos Genomics, BioSkryb Genomics, Source Genomics, Genoox, Nucleome Informatics Private Limited, Praxis Genomics LLC, Phase Genomics Inc., Daicel Arbor Biosciences, Nabsys, OpGen, Genohub Inc.

What Are the Primary Growth Drivers in the Optical Genome Mapping Market?

The escalation in the requirement for precision medicine is projected to boost the advancement of the optical genome mapping market. Precise medical treatment and prevention strategies designed according to individual traits such as genetic makeup, lifestyle, and environment formulate precision medicine. The growing prevalence of chronic illnesses, developments in genomic technologies, escalating investments and funding, and the increasing patient desire for personalized care, all contribute to the demand for precision medicine. The use of optical genome mapping serves to enrich precision medicine by presenting a comprehensive and precise comprehension of the genetic modifications related to diverse diseases. For example, in February 2024, the FDA sanctioned 16 new personalized therapies for individuals with rare diseases in 2023, as noted by the Personalized Medicine Coalition, a non-profit organization based in the US, in contrast to six in 2022. Thus, a surge in precision medicine demand propels the optical genome mapping market’s expansion.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=15882&type=smp

What Are the Leading Segments in the Global Optical Genome Mapping Industry?

The optical genome mapping market covered in this report is segmented –

1) By Product: Instruments, Consumables And Reagents, Software, Services

2) By Application: Structural Variant Detection, Genome Assembly, Microbial Strain Typing, Other Applications

3) By End-User: Biotechnology And Pharmaceutical Companies, Clinical Laboratories, Academic Research Institutes, Other End-Users

Subsegments:

1) By Instruments: Optical Genome Mapping Systems, Imaging Systems, Detection And Analysis Devices

2) By Consumables And Reagents: DNA Preparation Kits, Labeling Reagents, Flow Cells

3) By Software: Data Analysis Software, Image Processing Software, Mapping Software

4) By Services: Data Analysis Services, Technical Support Services, Training And Consultation Services

What Are the Key Market Trends in the Optical Genome Mapping Industry?

Key players in the optical genome mapping market are focused on creating laboratory-developed tests (LDTs) through optical genome mapping to boost diagnostic precision and deliver more in-depth genomic data. These LDTs, designed and built within individual clinical laboratories, use optical genome mapping (OGM) technology. An example of this occurred in September 2022, when Bionano Genomics Inc., a US firm that offers genome analysis software, introduced an OGM-based LDT for facioscapulohumeral muscular dystrophy (FSHD). This OGM-informed LDT will allow Bionano Laboratories to provide services to clients interested in integrating OGM into their diagnostic processes and in conducting research projects in partnership with hospitals, pharmaceutical firms, and other entities.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/optical-genome-mapping-global-market-report

What Is the Regional Outlook for the Optical Genome Mapping Market?

North America was the largest region in the optical genome mapping market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the optical genome mapping market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15882

This Report Delivers Insight On:

1. How big is the optical genome mapping market, and how is it changing globally?

2. Who are the major companies in the optical genome mapping market, and how are they performing?

3. What are the key opportunities and risks in the optical genome mapping market right now?

4. Which products or customer segments are growing the most in the optical genome mapping market?

5. What factors are helping or slowing down the growth of the optical genome mapping market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Optical Genome Mapping Market?

The growing demand for precision medicine is expected to advance the optical genome mapping market. Precision medicine, driven by genomics and personalized care trends, benefits from detailed genomic insights. Optical genome mapping supports disease-specific treatment strategies. In February 2024, the Personalized Medicine Coalition stated that the FDA approved 16 new personalized treatments in 2023, up from six in 2022. As such, the optical genome mapping market is growing with precision medicine adoption.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15882&type=smp

#How Does the ProjectedOptical Genome Mapping Market Growth Compare Over the Forecast Period?

The optical genome mapping market experienced exponential growth, increasing from $0.17 billion in 2024 to $0.23 billion in 2025 at a CAGR of 29.7%. Key drivers include demand for advanced genomic tools, large-scale genome research, academic and clinical collaborations, adoption by research labs and pharma companies, and cost-effective, high-accuracy genome analysis.

The optical genome mapping market is expected to reach $0.63 billion in 2029, growing at a CAGR of 29.4%. Growth is attributed to advancements in genomic research, the rise of precision medicine, increasing government funding, robust healthcare infrastructure, and the growing prevalence of genetic diseases and cancer. Trends include advanced OGM services, genomic research initiatives, advancements in DNA mapping, and AI and ML-driven genomic data processing.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15882

What Are the Key Market Innovations in theOptical Genome Mapping Market Over the Coming Years?

Major companies in the optical genome mapping market are advancing diagnostic tools through laboratory-developed tests (LDTs). In September 2022, Bionano Genomics Inc. launched an OGM-based LDT for diagnosing facioscapulohumeral muscular dystrophy, enhancing diagnostic and research capabilities.

Who Are the Top Companies Driving Innovation and Growth in theOptical Genome Mapping Market?

Major companies operating in the optical genome mapping market are Agilent Technologies Inc., Illumina Inc., PerkinElmer Genomics, Bio-Rad Laboratories Inc., Qiagen N.V., Cerba Healthcare, GenScript Biotech Corporation, 10x Genomics Inc., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., NanoString Technologies Inc., MedGenome, Element Biosciences, Bionano Genomics Inc., Stratos Genomics, BioSkryb Genomics, Source Genomics, Genoox, Nucleome Informatics Private Limited, Praxis Genomics LLC, Phase Genomics Inc., Daicel Arbor Biosciences, Nabsys, OpGen, Genohub Inc.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/optical-genome-mapping-global-market-report

Which Key Market Segments Comprise the Optical Genome Mapping Market and Drive Its Revenue Growth?

The optical genome mapping market covered in this report is segmented –

1) By Product: Instruments, Consumables And Reagents, Software, Services

2) By Application: Structural Variant Detection, Genome Assembly, Microbial Strain Typing, Other Applications

3) By End-User: Biotechnology And Pharmaceutical Companies, Clinical Laboratories, Academic Research Institutes, Other End-Users

Subsegments:

1) By Instruments: Optical Genome Mapping Systems, Imaging Systems, Detection And Analysis Devices

2) By Consumables And Reagents: DNA Preparation Kits, Labeling Reagents, Flow Cells

3) By Software: Data Analysis Software, Image Processing Software, Mapping Software

4) By Services: Data Analysis Services, Technical Support Services, Training And Consultation Services

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=15882&type=smp

Which Regions Are Emerging as Leaders in the Optical Genome Mapping Market?

North America was the largest region in the optical genome mapping market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the optical genome mapping market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Optical Genome Mapping Market 2025, By The Business Research Company:

Optical Goods Stores Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/optical-goods-stores-global-market-report

Optical Measurement Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/optical-measurement-global-market-report

Optical Imaging Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/optical-imaging-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: